<DOC>
	<DOCNO>NCT00218530</DOCNO>
	<brief_summary>Stress one common reason cite addict continual drug use relapse . Treatment approach target drug-induced stress-induced relapse may prove beneficial target drug-induced relapse alone . Lofexidine drug reduces physical symptom opiate withdrawal may prove stress-reducing capabilites drug addict . The purpose study determine maximal safe dose lofexidine tolerate naltrexone-treated heroin addict find optimal lofexidine induction schedule .</brief_summary>
	<brief_title>Effectiveness Naltrexone Lofexidine Treating Detoxified Heroin Addicts - 1</brief_title>
	<detailed_description>Stress one common reason cite addict continual drug use relapse . Naltrexone treatment opiate addict suffers high rate drop-out relapse . This may result naltrexone 's inability reduce symptom stress early recovery . Treatment approach target drug-induced stress-induced relapse may prove beneficial target drug-induced relapse alone . Lofexidine drug reduces physical symptom opiate withdrawal may prove stress-reducing capability . The purpose study determine maximal safe dose lofexidine tolerate naltrexone-treated opiate addict find optimal lofexidine induction schedule . The study also assess side effect occur discontinuation phase lofexidine . This pilot study last total 8 week . Recently detoxify opiate dependent participant eligible naltrexone treatment enter 4-week single-blind dose tolerability phase , participant receive naltrexone 1 3 twice-daily lofexidine induction schedule . All participant require remain clinic 2 hour immediately follow dose order monitor vital sign side effect . Study visit occur three time week , time naltrexone medication self-administration hand participant evaluate term tolerability treatment . After 4 week treatment , double-blind lofexidine detoxification phase use 5-day taper occur . Participants randomly assign one two maintenance-taper schedule . The first group undergo 5-day tapering , follow placebo three week , follow 5-day taper Week 4 . Withdrawal symptoms side effect evaluate .</detailed_description>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Lofexidine</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Meets DSMIV criterion opiate dependence Use heroin least 3 time per week 3 month prior enter opiate detoxification Documented positive urine toxicology test opiates Successful initiation naltrexone treatment indicate stabilization 50 mg naltrexone day Reads English Regular use anticonvulsant , sedatives/hypnotics , prescription analgesic , antihypertensive ( include clonidine ) , antirythmics , antiretroviral medication , tricyclic antidepressant Psychotic otherwise severely psychiatrically disabled ( e.g. , suidical , homicidal , currently manic ) Abstinent opiates four week prior naltrexone initiation Any medical problem might make naltrexone treatment unsafe , hepatocellular injury evidence abnormal liver enzyme test ( include SGOT , SGPT , GGT level great three time normal ) history cirrhosis Hypotension rest blood pressure 90/50 mm Hg Pregnant , breastfeeding , refusal use reliable form contraception throughout study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>